Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06954779 · ClinicalTrials.gov registry record · Phase 3
Arginine Plaque Metabolism Pilot Clinical Study
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT06954779: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT06954779 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06954779, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.
Primary Outcome
Fasting plaque will be collected before and after a sucrose rinse for lactic acid analysis and ammonia production.The plaque pH of collected samples will also be measured to provide trend data.
Interventions
- DRUG Colgate Cavity Protection
- DRUG TOM's Superior Sensitivity Relief Toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2024-09-20 |
| Phase | Phase 3 |
What the finished NCT06954779 record still lists
NCT06954779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Colgate Cavity Protection is the first listed.
NCT06954779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06954779 about?
NCT06954779 is a clinical study titled "Arginine Plaque Metabolism Pilot Clinical Study". Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.
What is the current status of trial NCT06954779?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2024-07-24. Estimated completion is 2024-09-20.
What interventions are being tested in trial NCT06954779?
The interventions under investigation include: Colgate Cavity Protection (DRUG), TOM's Superior Sensitivity Relief Toothpaste (DRUG).
Who is sponsoring clinical trial NCT06954779?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06954779's enrollment target sits among peer trials
20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI